Schrodinger raises $232M in IPO
Drug discovery software company Schrödinger raised $232 million in its IPO, which closed Monday. The company’s stock was trading at $27.22 on Tuesday.
AI drug discovery company Recursion Pharmaceuticals raises $121M Series C
Recursion's technology works by generating millions of cellular images and using AI-based software as a way to analyze the data set and screen potential therapeutic compounds against a variety of diseased cells.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.